Cilo Cybin Hit With Accounting Adjustment, Posts Shock R241 m loss for Year Ending March 2026

Cilo Cybin Ltd has posted its results for the year ending March 2026 with a surprise loss from operating activities of R241,1 million, due mostly to an accounting provision related to the reverse take over of Cilo Cybin Pharmaceuticals ahead of its JSE main board listing last year.

Four years on, SAHPRA Remains in Breach of Supreme Court Over Herbal Remedies

Four years ago, the Supreme Court of Appeal ruled that SAHPRA had overstepped its powers in regulating vitamins, minerals and herbal remedies as though they were pharmaceutical drugs. Little has changed. This BizNews investigation, by Marika Sboros, digs into what’s going on behind the scenes.

Call for eSwatini to Host SADC Cannabis and Hemp Roundtable Next Year

eSwatini’s first hemp concessionaires have appealed to King Mswati III to host a SADC cannabis summit next year. Joe Mkhabela and Johan Botha of African Hemp Development and Management made the appeal when they met the King at eSwatini’s International Trade Fair recently.